Diagnostic Products Corporation Schedules Conference Call to Discuss First Quarter 2006 Results
22 April 2006 - 12:19AM
Business Wire
Diagnostic Products Corporation (NYSE:DP) announced today that it
has scheduled a conference call to discuss the Company's financial
results of its first quarter 2006 on Thursday, April 27, 2006, at
11:30 a.m. Eastern daylight time (8:30 a.m. PDT). The Company plans
to release its financial results before the market opens on
Thursday. If you are interested in participating in the call,
please call 719-457-2731 or 800-481-9591 on the day of the
conference, at least ten minutes prior to the conference in order
for the operator to tie you into the call. The operator will ask
you to identify the call with the company name Diagnostic Products
Corporation-Jim Brill. An "instant replay" of the call will be
available until May 5. If you would like to take advantage of this
special service, you can access it via 719-457-0820 or 888-203-1112
and the code: "5707457." It usually takes two hours following the
conference to set up the recording. About Diagnostic Products
Corporation Diagnostic Products Corporation, founded in 1971, is a
leader in the global in vitro diagnostics market. DPC's product
offering includes the widely accepted IMMULITE(R) series of
immunoassay systems, more than 75 immunoassays and an expanding
menu of essential specific allergens and allergy panels that are
run just like other immunoassays. DPC also designs and manufactures
automated laboratory instrumentation and automation solutions that
provide fast, accurate results while enabling our customers to do
"more with less" in a leaner laboratory. DPC's combined chemistry
and immunoassay menu is one of the largest and most diversified
available, covering most laboratory tests requested. DPC sells its
products to hospitals, clinics and laboratories in more than 100
countries. Additional Company information can be found on DPC's
website at www.dpcweb.com. Except for the historical information
contained herein, this press release contains forward-looking
statements that involve risks and uncertainties that could cause
actual results to differ materially. These factors include
governmental or other action relating to the Company's Chinese
affiliate; the rate of customer demand for the Company's products;
the Company's ability to successfully market new and existing
products; its dependence on certain suppliers; domestic and foreign
government regulation; its ability to keep abreast of technological
innovations and to translate them into new products; competition;
political and economic instability in certain markets, including
the movements of foreign currencies relative to the dollar; and
other risks and uncertainties disclosed from time to time in the
Company's SEC reports and filings.
Diagnostic Products (NYSE:DP)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Diagnostic Products (NYSE:DP)
Historical Stock Chart
Von Mai 2023 bis Mai 2024
Echtzeit-Nachrichten über Diagnostic Products (New York Börse): 0 Nachrichtenartikel
Weitere Diagnostic Products Corporation News-Artikel